- Filed
- Jan 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 153.92M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 152.06M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 149.03M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 149.13M sh |
| Capex | Q3 2026 · Dec 31, 2025 | $31.46M |
| Capex | Q3 2026 · Dec 31, 2024 | $23.84M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | $391.48M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | $418.47M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $952.62M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $766.1M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $2.15B |
| Stockholders Equity | Q3 2026 · Sep 26, 2025 | $1.99B |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $1.63B |
| Stockholders Equity restated | Q3 2026 · Dec 31, 2024 | $1.42B |
| Stockholders Equity | Q3 2026 · Sep 27, 2024 | $1.28B |
| Stockholders Equity restated | Q3 2026 · Mar 31, 2024 | $992.03M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $1.08B |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $1.03B |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $1.65B |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $1.56B |
| Current Assets | Q3 2026 · Dec 31, 2025 | $2.56B |
| Current Assets | Q3 2026 · Mar 31, 2025 | $2.16B |
| Total Assets | Q3 2026 · Dec 31, 2025 | $3.8B |
| Total Assets | Q3 2026 · Mar 31, 2025 | $3.19B |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.85 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $2.86 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $0.79 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $2.41 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.88 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $2.94 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $0.80 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $2.46 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $82.73M |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $241.3M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $70.57M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $203.53M |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $29.29M |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $77.74M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $20.09M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $55.81M |
| Net Income | Q3 2026 · Dec 31, 2025 | $131.24M |
| Net Income | Q3 2026 · Dec 31, 2025 | $435.28M |
| Net Income | Q3 2026 · Dec 31, 2024 | $115.28M |
| Net Income | Q3 2026 · Dec 31, 2024 | $352.37M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $176.11M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $543.68M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $150.24M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $443.81M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $288.13M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $862.72M |
| Gross Profit | Q3 2026 · Dec 31, 2024 | $240.9M |
| Gross Profit | Q3 2026 · Dec 31, 2024 | $703.14M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $621.22M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $1.82B |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $438.46M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $1.33B |
| Revenue | Q3 2026 · Dec 31, 2025 | $909.35M |
| Revenue | Q3 2026 · Dec 31, 2025 | $2.68B |
| Revenue | Q3 2026 · Dec 31, 2024 | $679.36M |
| Revenue | Q3 2026 · Dec 31, 2024 | $2.03B |